Harvard bioscience q1 adjusted loss per share $0.01

Harvard bioscience announces first quarter 2020 financial results.q1 adjusted loss per share $0.01.q1 loss per share $0.12.q1 revenue $23.8 million versus refinitiv ibes estimate of $27.9 million.sees q2 revenue down about 20 to 30 percent.q1 earnings per share estimate $0.03 -- refinitiv ibes data.withdrawing full-year 2020 financial guidance previously provided on february 26.

HBIO Ratings Summary

HBIO Quant Ranking